On November 15
th, the 53
rd MEDICA was unveiled in Dusseldorf. As a global medical exposition, MEDICA welcomes healthcare providers from around the world. Wondfo exhibited COVID-19 Total Solution, covering screening, diagnosis, clinical management of multiple indicators and post-vaccination screening.
Click
here to view the scene in video.
For entering the Expo, a record of fully vaccination or negative test result is required. Beside the entrance of MEDICA was a test center for those who want a COVID-19 test report. Wondfo assisted in the pandemic control with our 2019-nCoV antigen tests applied in the test center. The test result would be sent with an email about 10 minutes after sampling.
Since the founding of Wondfo in 1992, we have been devoted to and famous for our colloidal gold tests. At the initial outbreak of the pandemic last year, Wondfo took immediate actions to curb the pandemic and safeguard people’s health. In September last year, Wondfo 2019-nCoV antigen test gained CE marking for professional testing and screening. And in June this year, Wondfo’s antigen self-test for home use was approved for CE marking, too. Together with other colloidal gold test for coronavirus, Wondfo provides rapid and convenient COVID-19 rapid tests for various scenarios.
For decades, Wondfo has been deeply engaged in R&D of medical materials with latest technologies. Besides various colloidal gold antigen tests, we offer healthcare providers with a COVID-19 Total Solution, meeting needs for molecular diagnosis, monitoring of severity-indicating markers and evaluation of antibody concentration.
The lately launched Wondfo U-Card Dx™ Automated Rapid Molecular Diagnostic Instrument was first exhibited in MEDICA. With promised lab-quality results delivered in 30-45 minutes, it is designed as a fully automated and fully enclosed instrument, thus minimizing manual handling and avoiding biosafety contamination, making it suitable for respiratory Infections diagnosis in multiple scenarios.
After a year’s break due to the pandemic, we are excited to meet you face to face again at such a global Expo. Wondfo has been, and will always been protecting people’s health and happiness. Racing for Life.
For our latest news, you may follow us in LinkedIn or Facebook.
The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Single-dose Chemiluminescense Immunoassay Platform
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.
Ready-to-use lyophilized RT-PCR Reagent；
Wondfo PA-3600 IHC Staining System
Advanced rapid diagnostic test with WHO prequalification for infectious disease
The Future Intelligent Medical Assistant to Healthcare
Fight against the pandemic through continuous innovation
